The Latest Cardiac and Vascular News
EDEN PRAIRIE, Minn., May 3, 2023 /PRNewswire/ — MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in the company’s clinical trial to assess the safety and effectiveness of the Q™ Revascularization System for the treatment of acute ischemic stroke (EVAQ Trial). The EVAQ Trial enrolled 121 patients at 17 centers […]
EDEN PRAIRIE, Minn., June 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has successfully achieved first-in-man usage of the DAISe Clot Management System for next generation treatment of ischemic stroke. The proprietary DAISe Clot Management System is uniquely designed to remove clot as well as filter / capture clot emboli that fracture during removal. DAISe features […]
EDEN PRAIRIE, Minn., March 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has received CE Mark approval for the R4Q Revascularization Catheter for the removal of fresh, soft emboli and thrombi in the peripheral and neurovascular systems. The CE Mark approval is a significant accomplishment for MIVI Neuroscience. This approval enables the company to market and sell […]
